Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13178
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNayler, W Gen
dc.date.accessioned2015-05-16T02:58:11Z
dc.date.available2015-05-16T02:58:11Z
dc.date.issued1994-05-16en
dc.identifier.citationBasic Research in Cardiology; 89 Suppl 1(): 137-43en
dc.identifier.govdoc7945168en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13178en
dc.description.abstractAtherosclerosis is a multifactorial disease which culminates in the ruptured plaque seen at autopsy. Hypercholesterolaemia, subintimal accumulation of lipid, monocyte adhesion followed by penetration across the endothelium, the conversion of monocytes to macrophages and smooth muscle cell proliferation and migration are some of the events involved in the early stages of lesion formation. Late events include the formation of excess ground substance and collagen, and the formation of the fibrotic cap. Young lesions tend to be more fragile than "old" calcified lesions, and it is these young lesions which rupture, haemorrhage and provide anchor points for platelets. Therapeutic interventions aimed at controlling lesion formation include those which reduce risk factors, including hypertension as well as those which interfere with the cascade of events involved in lesion formation. Agents which lower plasma cholesterol provide one approach. Another approach is to use calcium antagonists which not only lower blood pressure, but also directly interfere with some of the metabolic events involved in lesion formation.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherAorta.metabolism.pathologyen
dc.subject.otherCalcium.analysisen
dc.subject.otherCholesterol.blooden
dc.subject.otherCholesterol, Dietaryen
dc.subject.otherCoronary Artery Disease.chemically induced.drug therapyen
dc.subject.otherDiet, Atherogenicen
dc.subject.otherMaleen
dc.subject.otherNifedipine.therapeutic useen
dc.subject.otherNisoldipine.therapeutic useen
dc.subject.otherRabbitsen
dc.titleTherapeutic approaches to the control of coronary atherosclerosis.en
dc.typeJournal Articleen
dc.identifier.journaltitleBasic research in cardiologyen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australiaen
dc.description.pages137-43en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/7945168en
dc.type.austinJournal Articleen
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

2
checked on Apr 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.